Heart Test Laboratories  logo
HSCSHeart Test Laboratories
Trade HSCS now
Heart Test Laboratories  primary media

About Heart Test Laboratories

Heart Test Laboratories (NASDAQ:HSCS) specializes in innovative cardiac health solutions, focusing primarily on developing and marketing advanced electrocardiogram (ECG) technologies. Their flagship project, the MyoVista wavECG Technology, aims to significantly improve the detection of heart disease by incorporating cutting-edge machine learning algorithms with traditional ECG techniques. The objective of Heart Test Laboratories is to enhance early diagnosis and monitoring of heart disease, striving to make cardiac care more accessible and effective for patients worldwide. Through continuous research and development, the company is committed to pushing the boundaries of what's possible in cardiac diagnostics, ensuring better health outcomes for individuals at risk of heart disease.

What is HSCS known for?

Snapshot

Public US
Ownership
2007
Year founded
12
Employees
Southlake, United States
Head office
1 of 3
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
United States

Products and/or services of Heart Test Laboratories

  • MyoVista wavECG Technology - A groundbreaking device that combines traditional ECG heart testing with proprietary waveform technology to detect cardiac dysfunction.
  • High Sensitivity ECG - An advanced version of the standard ECG, melding precise detection capabilities with an algorithm to improve the identification of heart disease.
  • Cardiac Risk Analysis Software - An intuitive software that analyzes ECG readings to provide healthcare professionals with a comprehensive risk assessment for cardiovascular diseases.
  • Mobile ECG Solutions - Portable devices designed to offer flexible and convenient heart monitoring and diagnostics, enhancing patient care outside traditional settings.
  • Heart Health Education Programs - Comprehensive programs aimed at educating healthcare providers and patients on the importance of early detection and management of heart conditions.
  • Remote Patient Monitoring Services - A service that allows for the remote collection and analysis of ECG data, ensuring continuous cardiac health monitoring.

Heart Test Laboratories executive team

  • Mr. Andrew SimpsonCEO, President & Chairman of the Board of Directors
  • Ms. Danielle WatsonCFO & Treasurer
  • Mr. Mark T. HilzCOO, Secretary & Director

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.